Approval · Notice of Compliance 25438 · 2021
RIXUBIS: Notice of Compliance 25438
Issued March 12, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25438
- Date
- March 12, 2021
- Company
- Takeda Canada IncorporatedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Labelling Only
- Reason
- Transfer of drug identification number. labelling updates
Products in this notice
Medicinal ingredients
- NONACOG GAMMA 250 UNIT per VIAL
- NONACOG GAMMA 500 UNIT per VIAL
- NONACOG GAMMA 1,000 UNIT per VIAL
- NONACOG GAMMA 2,000 UNIT per VIAL
- NONACOG GAMMA 3,000 UNIT per VIAL